SNU-182 cells
Cat# C0015003
Size : OneFrozenvial
Contatta il distributore locale :
Disease:
Carcinoma, hepatocellular; grade III/IV
Origin:
SNU-182 was derived in 1989 by J.-G. Park and associates from a primary hepatocellular carcinoma taken from a Asian patient prior to cytotoxic therapy.
Species:
Homo sapiens, human Liver Epithelial Adherent aneuploid; modal number = 70 Male, 24 years of age, Asian AddexBio-formulated RPMI-1640 Medium (C0004-01) + 10% FBS Split sub-confluent cultures (70-80%) at a subcultivation ratio of 1:3 to 1:6 is recommended. Subculture at higher cell density is recommended. Culture at 5% CO2, 37°C. Complete culture medium supplemented with 7.5% (v/v) DMSO II Bacteria: Negative Yeast: Negative Mycoplasma: Negative HIV: Negative Hepatitis C: Negative Amelogenin: X,Y CSF1PO: 10,12 D13S317: 11,14 D16S539: 11,13 D5S818: 11,12 D7S820: 11 THO1: 9 TPOX: 8,11 vWA: 17 If use of this culture results in a scientific publication, it should be cited in the publication as: SNU-182 (AddexBio C0015003) Tissue:
Morphology:
Properties:
Cytogenic data:
Patient:
Medium:
Subculture:
Freezing Medium:
Biosafety Level:
Sterility:
Pathogens:
DNA Profile (STR):
Citation Format:
References for SNU-182 cells:
1. Park JG, Lee JH, Kang MS, Park KJ, Jeon YM, Lee HJ, Kwon HS, Park HS, Yeo KS, Lee KU, et al. Characterization of cell lines established from human hepatocellular carcinoma. Int J Cancer. 1995;62(3):276-282. PMID: 7543080